NewEdge Advisors LLC Has $2.77 Million Holdings in Columbia Research Enhanced Value ETF $REVS

NewEdge Advisors LLC lessened its stake in shares of Columbia Research Enhanced Value ETF (NYSEARCA:REVSFree Report) by 16.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 96,918 shares of the company’s stock after selling 18,492 shares during the quarter. NewEdge Advisors LLC’s holdings in Columbia Research Enhanced Value ETF were worth $2,774,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in REVS. Raymond James Financial Inc. grew its stake in shares of Columbia Research Enhanced Value ETF by 396.4% during the second quarter. Raymond James Financial Inc. now owns 200,098 shares of the company’s stock valued at $5,259,000 after purchasing an additional 159,786 shares during the last quarter. Private Advisor Group LLC bought a new stake in Columbia Research Enhanced Value ETF in the third quarter valued at about $448,000. World Investment Advisors acquired a new position in Columbia Research Enhanced Value ETF in the fourth quarter valued at about $1,169,000. Essex Financial Services Inc. boosted its holdings in Columbia Research Enhanced Value ETF by 108.5% during the fourth quarter. Essex Financial Services Inc. now owns 24,626 shares of the company’s stock worth $697,000 after buying an additional 12,815 shares during the last quarter. Finally, LPL Financial LLC boosted its holdings in Columbia Research Enhanced Value ETF by 24.6% during the fourth quarter. LPL Financial LLC now owns 2,249,697 shares of the company’s stock worth $63,628,000 after buying an additional 443,608 shares during the last quarter.

Columbia Research Enhanced Value ETF Trading Up 0.5%

Columbia Research Enhanced Value ETF stock opened at $34.00 on Friday. The firm has a market capitalization of $340 million, a P/E ratio of 16.41 and a beta of 0.79. The business has a 50-day moving average of $32.48 and a 200-day moving average of $30.76. Columbia Research Enhanced Value ETF has a 1 year low of $27.13 and a 1 year high of $34.03.

Columbia Research Enhanced Value ETF Profile

(Free Report)

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.

See Also

Want to see what other hedge funds are holding REVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Columbia Research Enhanced Value ETF (NYSEARCA:REVSFree Report).

Institutional Ownership by Quarter for Columbia Research Enhanced Value ETF (NYSEARCA:REVS)

Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.